Article Details
Retrieved on: 2019-06-02 23:29:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Abrams Capital Management Lp increased its stake in Akebia Therapeutics Inc (AKBA) by 405.36% based on its latest 2018Q4 regulatory filing with ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here